GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a significant focus in medical investigation, largely due to its impressive impact on treating diseases such as second type diabetes and excess body fat. Recent trials have shown that more than glucose control, GLP-1